Your browser doesn't support javascript.
loading
Acceptability of risk-tailored cancer screening among Australian GPs: a qualitative study.
LA Dunlop, Kate; Smit, Amelia K; Keogh, Louise A; Newson, Ainsley J; Rankin, Nicole M; Cust, Anne E.
Afiliación
  • LA Dunlop K; The Daffodil Centre, a joint venture with Cancer Council NSW and Melanoma Institute Australia, University of Sydney, Sydney.
  • Smit AK; The Daffodil Centre, a joint venture with Cancer Council NSW and Melanoma Institute Australia, University of Sydney, Sydney.
  • Keogh LA; Centre for Health Equity, Melbourne School of Population and Global Health, University of Melbourne, Melbourne.
  • Newson AJ; Faculty of Medicine and Health, Sydney School of Public Health, Sydney Health Ethics, University of Sydney, Sydney.
  • Rankin NM; Evaluation and Implementation Science Unit, Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne.
  • Cust AE; The Daffodil Centre, a joint venture with Cancer Council NSW and Melanoma Institute Australia, University of Sydney, Sydney.
Br J Gen Pract ; 74(740): e156-e164, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38373853
ABSTRACT

BACKGROUND:

Cancer screening that is tailored to individual risk has the potential to improve health outcomes and reduce screening-related harms, if implemented well. However, successful implementation depends on acceptability, particularly as this approach will require GPs to change their practice.

AIM:

To explore Australian GPs' views about the acceptability of risk-tailored screening across cancer types and to identify barriers to and facilitators of implementation. DESIGN AND

SETTING:

A qualitative study using semi-structured interviews with Australian GPs.

METHOD:

Interviews were carried out with GPs and audio-recorded and transcribed. Data were first analysed inductively then deductively using an implementation framework.

RESULTS:

Participants (n = 20) found risk-tailored screening to be acceptable in principle, recognising potential benefits in offering enhanced screening to those at highest risk. However, they had significant concerns that changes in screening advice could potentially cause confusion. They also reported that a reduced screening frequency or exclusion from a screening programme for those deemed low risk may not initially be acceptable, especially for common cancers with minimally invasive screening. Other reservations about implementing risk-tailored screening in general practice included a lack of high-quality evidence of benefit, fear of missing the signs or symptoms of a patient's cancer, and inadequate time with patients. While no single preferred approach to professional education was identified, education around communicating screening results and risk stratification was considered important.

CONCLUSION:

GPs may not currently be convinced of the net benefits of risk-tailored screening. Development of accessible evidence-based guidelines, professional education, risk calculators, and targeted public messages will increase its feasibility in general practice.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Actitud del Personal de Salud / Investigación Cualitativa / Detección Precoz del Cáncer / Médicos Generales Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: Br J Gen Pract Año: 2024 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Actitud del Personal de Salud / Investigación Cualitativa / Detección Precoz del Cáncer / Médicos Generales Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: Br J Gen Pract Año: 2024 Tipo del documento: Article